Cleerly Ischemia
Device Cardiology/Vascular Diseases
PDI 00860001924121
General payments
$182,970
Research payments
$1,955,427
Through program year 2025, $182,970 in general payments and $1,955,427 in research payments were reported against Cleerly Ischemia (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $139,355 | 2,769 |
| 2025 | Research | $1,156,009 | 51 |
| 2024 | General | $43,615 | 820 |
| 2024 | Research | $799,417 | 89 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 79 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,589 general · 140 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.